Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$242K Sell
4,465
-85
-2% -$4.48K 0.02% 284
2016
Q1
$230K Sell
4,550
-240
-5% -$12K 0.02% 280
2015
Q4
$242K Sell
4,790
-655
-12% -$33.4K 0.02% 279
2015
Q3
$262K Sell
5,445
-180
-3% -$9.37K 0.02% 274
2015
Q2
$292K Buy
5,625
+160
+3% +$9.01K 0.02% 265
2015
Q1
$316K Buy
+5,465
New +$313K 0.03% 254
2014
Q4
Sell
-3,582
Closed -$206K 312
2014
Q3
$206K Buy
+3,582
New +$220K 0.02% 295

Other funds holding GSK

FirstMerit Bank N.A. Trustee's GSK Position: Q2 2016 in Review

FirstMerit Bank N.A. Trustee reduced its GSK (GSK) stake by 1.9% in Q2 2016, selling an estimated $4.48K and leaving 4,465 shares worth $242K. The position accounts for 0.02% of the portfolio, ranked #284.

FirstMerit Bank N.A. Trustee first reported a position in GSK in Q3 2014 and has held it in 7 quarters since. The position peaked at $316K in Q1 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • FirstMerit Bank N.A. Trustee held 4,465 shares of GSK worth $242K as of Q2 2016.
  • FirstMerit Bank N.A. Trustee sold 85 GSK shares in Q2 2016, an estimated $4.48K.
  • GSK made up 0.02% of FirstMerit Bank N.A. Trustee's portfolio in Q2 2016, its #284 holding.
  • FirstMerit Bank N.A. Trustee first reported a position in GSK in Q3 2014 and has held it in 7 quarters since.
  • FirstMerit Bank N.A. Trustee's GSK position peaked at $316K in Q1 2015.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on FirstMerit Bank N.A. Trustee's 13F filing for Q2 2016, filed 11 Jul 2016.